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ABSTRACT
We have developed a technique of homologous
recombination in bacteria which allows the
mutagenesis of large genomic fragments cloned in
cosmids. The desired mutation is first introduced into
a plasmid clone and is then transferred to the
appropriate cosmid clone by the means of double
antibiotic selection coupled with phenotypic selection.
We describe three different types of construct made
by this technique.
INTRODUCTION
In studies of gene expression, it is important to be able to mutate
small regions of cloned DNA in a directed and precise manner.
This can be accomplished by removing or inserting small
segments ofDNA from plasmids by restriction enzyme digestion
and ligation, or by site directed mutagenesis. These techniques
are accomplished most easily in the context of small fragments
of DNA cloned in plasmids; indeed, this is an absolute
requirement for site directed mutagenesis (1). However, it is
frequently necessary to reintroduce these mutated sections into,
for example, genes cloned in cosmids and this is technically both
difficult and imprecise, since it relies on the presence of naturally
occurring restriction sites. We have developed a technique for
modifying large genomic clones by homologous recombination
in E. Coli. This technique is of widely applicable benefit since
any small mutation can be introduced into any large genomic
context without the need for particular restriction sites. We have
used this technique to generate mutations in two human genes
linked (in vitro) for use in transgenic mouse studies. It is often
useful to be able to have two genes linked in tandem for
expression studies, particularly where the genes are functionally
related, for example, coding for different subunits of the same
protein, or coding for proteins acting in the same pathway or
expressed in the same tissue. In this case, the genes chosen were
those for human al-antitrypsin (AlAT) and human retinol-binding
protein (RBP) both of which are expressed in liver (2). RBP was
present as an internal control for variation in AlAT expression.
We describe here three uses of the homologous recombination
protocol: -the insertion of a short heterologous reporter gene,
the mutation of short cis-acting elements in the A1AT promoter
and the substitution of a single base pair in the AIAT coding
region.
MATERIALS AND METHODS
Homologous recombination procedure
This protocol is a modification of that described by Poustka et
al (3) . The bacterial strain used for each step was Escherichia
coli k12 rec A- DH1 (4). Antibiotic selection was performed
at 15 microgram/milliliter for kanamycin and 50
microgram/milliliter for ampicillin. In vitro packaging of cosmid
DNA was done with Gigapack (Stratagene) extract according to
the protocol recommended by the manufacture, with an average
efficiency of 1 x 104 per microgram of DNA. The analysis of
recombination in and out events was done by restriction mapping
and Southern hybridation; in the cases of PM1 and EM3, the
entire region of homology between donor and acceptor, after
recombination, has been controlled by subcloning and sequencing
by dideoxy-method (5). In the case of the PiZ construct,cosmids
were analysed by probing Southern blots with 'M' and 'Z'
specific oligonucleotides as described (6).
Several cases of inappropriate rearrangement within the cosmid
insert, both in recombination in and out events, were observed
and discarded.
Construction of plasmids and cosmids
pCos RBP/A1AT cosmid was obtained by ligation of the 18 kb
Sal fragment from the RBP gene (7) and the 17.5 kb Sall
fragment from the al-antitrypsin gene (1AT73) (8), into the Sall
site of pCos2 (3). This cosmid was used as acceptor in an
homologous recombination reaction in E. Coli in order to insert
the CAT coding region downstream of the RBP promoter. The
donor was a pEMBL-CAT derivative containing the HindIl-Clal
segment from PSV2-CAT (9) flanked at the 5' end by a segment
of the RBP gene, from N -1650 to N + 36 and at the 3' end
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by another segment of the RBP gene, from N +59 to N +448.
The resulting cosmid (pCos RBP-CAT/A1AT) was used as
acceptor in three independent reactions in which the donors were
in the first two cases described pEMBL 18 containing the
promoter of the AlAT gene from -261 to -37, carrying the EM3
or the PM1 mutations (10) In the third reaction the donor was
pUC9 containing a 402 bp amplified fragment. This was derived
by PCR of DNA from an individual homozygous for the PiZ
mutation. The primers were as described (6). The product was
cloned into the Smal site of the vector by blunt-ended ligation.
The insert was sequenced using a double-stranded sequencing
protocol and was found to be identical to that of the published
sequence of AlAT (11), apart from the G-A substitution
characteristic of the PiZ allele.
RESULTS
General prnciple of the technique
In order to insert or delete sequences within the context of large
DNA segment we set up an in vivo homologous recombination
protocol, partially based on the work of Cesareni et al (12) and
Poustka et al. (3) which is outlined schematically in fig 1 and
described in more detail in materials and methods. The gene to
be modified is cloned in pCos2, a cosmid vector previously
described (3), carrying the kanamycin resistance gene. The salient
feature of pCos2, which is essential for this technique, is the lack
of any sequence homology with plasmids of the pUC (13) or
pEMBL families (14). A short ( 200-2500 nucleotides) DNA
sequence of the gene containing the desired mutation is cloned
in the plasmid which has the ampicillin resistance gene. The
salient feature of these vectors, is that 1) they do not contain any
sequence homologous to pCos2, so that the only homology is
within the test gene; 2) they carry a lac operator sequence. The
lac operator serves the purpose of conferring a phenotype to any
bacterial colony harboring a recombinant. This is because the
lac operator binds avidly to the lac repressor, causing the
derepression of the bacterial lac operon, with consequent high
amounts of beta-galactosidase activity, which can be easily
detected on X-gal plates. In the homologous recombination
experiment the recombinant plasmid functions as donor and the
pCos2 derivative cosmid functions as acceptor. It is thus possible
to infect bacterial cells harboring the donor plasmid, with
packaged acceptor cosmid ( fig. 1, step 1 ). After a few hours
of growth cells are harvested and the DNA extracted and
packaged. After a second round of infection ( fig. 1, step 2 ),
cells are plated on kan-amp-Xgal plates, to select and identify
the product of the single homologous recombination events (
which yield blue colonies ) carrying the donor plasmid
'recombined in' into the pCos2 acceptor ; usually between
1 x 10-2 and 10-a of the colonies are blue, apparently
depending on the size of the region of homology between donor
and acceptor constructs as described in detail below. The reverse
reaction, a 'recombination out' of the plasmid sequences, occurs
at a frequency between 10-2 to 10-3 In practice blue colonies
are grown for few hours, than DNA is extracted and packaged.
In a third round of infection, cells are plated on kan-X-gal plates:
colonies harboring the pCos2 DNA, without any plasmid
sequences, are white because the bacterial lac operon is normally
repressed. As shown in fig. 1., step 3, there are two possible
products of this ' recombination out ' event: A) the restoration
of the original wild-type pCos2 construct, which is the unwanted
product and B) the formation of a new construct carrying the
recombinantpCos24 transduce
P I
traneduce
select on AmnpKan
P I
transduce
select on Kean
white colony blue colony
white colony
Step 1
Step2
step 3
Fig 1. Homologous recombination protocol. Step]. The packaged recombinant
cosmid is transduced into a bacterial cell harbouring the 'donor' plasmid carrying
the desired mutation. The regions of homology between donor and acceptor varied
from experiment to experiment ( from 200 to 2000 nucleotides ). Infected cells
are grown for 4 hours in the presence of kan and amp, then are harvested and
DNA is extracted and purified. step2. DNA, containing donor plasmid, acceptor
cosmid and the cointegrate of donor and acceptor, is packaged in vitro and
transduced into bacterial cells. The free donor plasmid cannot be packaged, whereas
the free acceptor cosmid is counterselected in the presence of ampicillin, therefore
the only colonies carrying the cointegrate can grow in the presence of both kan
and amp. Step3. DNA is extracted and analyzed by restriction mapping and
Southern blot in order to eliminate incorrect or rearranged cointegrates. The
expected and verified cointegrate DNA is packaged again and transduced into
bacterial cells in the presence of kanamycin and X-gal. Colonies carrying the
product of the 'recombination out' event are white and are analysed for the presence
or absence of the desired mutation.
desired mutation, which is the wanted product. A and B can be
easily distinguished by colony hybridization with specific labelled
oligonucleotide probes (see fig. 3).
Details of constructs made
The CAT coding region was inserted into the human RBP gene.
The donor plasmid was a pEMBL-CAT derivative containing the
CAT coding sequence bracketed by about 1700 bp 5' and about
400 bp 3' of the human RBP gene. The extent of homology
between the inserts in this case was about 2100 bp, and the
frequency of 'recombination in' events, i.e. double antibiotic
resistant colonies, was 1/100. Of these, twelve were selected at
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Fig 2. Constructs made
random, amplified and analysed by restriction mapping with
EcoRl and BamHl independently. These enzymes give in the
order of ten bands each. Out of these twelve clones, eight gave
restriction patterns characteristic of the predicted integration into
the first exon of the RBP gene. The other four clearly had large
abnormal deletions, resulting in a restriction pattern which defied
analysis. One of the clones which had undergone the predicted
integration event was selected and grown in the presence of
kanamycin alone. DNA was extracted, packaged again and plated
on Xgal/Kanamycin plates. Of the resulting colonies 1/100 was
white. Ten of these were selected by colony hybridization with
the CAT specific probe and analyzed further by restriction
mapping and blotting. All of them showed the predicted pattern
for a correct replacement of the first exon of the RBP gene with
the equivalent exon containing the CAT gene.
The resulting cosmid recombinant, pCos-RBP-CAT/AIAT,
was used as acceptor for the recombination with DNA segments
carrying mutations in the AIAT promoter. For the construction
of these mutants, the plasmid donors were pEMBL derivatives
containing a 224 bp fragment of the AIAT promoter. The
mutations involved were PM1 and EM3 (10). In the case of PM1
the extent of homology was 220 bp and the frequency of
'recombination in' events was 1/3000. Ten of these colonies were
checked and nine were found to have the predicted restriction
pattern. One of these was grown and 60.000 bacterial colonies
were tested on Xgal plates. Six consistently white clones were
isolated, all of which had undergone the correct excision event,
and two of which were recombinants as judged by colony
hybridization and Southern blotting of restriction digests. The
identity of the recombinants was verified further by the cloning
and sequencing of the entire region of homology ( see matherials
and methods). In the case of EM3 the extent of homology was
218 bp and the frequency of 'recombination in' event was
1/10.000. One colony was grown and 10.000 bacterial colonies
were tested on Xgal plates. Ten white colonies were selected all
of which had undergone a correct event of 'recombination out'.
Analysis of these clones showed five of them to be the desired
constructs.
For the construction of the PiZ clone, a 402 bp fragment was
amplified by PCR using primers which span exon V plus a small
amount of flanking sequence (6), from DNA of a homozygous
PiZZ individual. PiZZ homozygotes have a deficiency of serum
AlAT due to the build-up of the mutant protein in the hepatocytes
(15). This fragment was cloned into pUC9 and used as a donor
in a reaction in which pCos-RBP-CAT/AIAT was used as an
acceptor. The frequency of recombination in events was 1/2000.
Of twenty colonies checked one showed the predicted restriction
pattern. This was selected for the 'recombination out' event which
occurred at a frequency of 1/500. Of ten colonies checked all
had undergone the correct excision event. These were checked
by hybridization with both M and Z specific oligonucleotides (16)
and one was found to be the desired Z clone. See fig 2 for the
hierarchy of the clones described above and fig 3 for an example
of the screening technique used for the 'recombination out' event.
Orientation of region of homology
The orientation of the region of homology which determines the
orientation of origin of replication in the plasmid relative to the
origin of replication in the cosmid does not appear to be of vital
importance for the success of this technique. This was established
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Fig3. Example of the screening technique used for the 'recombination out' event.
cA: acceptor cosmid ( RBP-CAT/A1AT); pD: donor plasmid (exon V of PiZ
AIAT allele); M: Size Marker; 1-7 Cosmids which have undergone to the
homologous recombination protocol. Panel A: EcoRI digests. Panel B: Southern
blot analysis of the gel shown in panel A probed with M specific oligonucleotides.
Panel C: same filter rehybridized with Z specific oligonucleotides. Clone 4 is
the desired product.
by cloning the insert containing the PM1 mutation in both
orientations in a plasmid. In each case, successful integration was
obtained. However, in one case we observed that the colonies
were unusually slow in growing after the integration event. These
colonies were derived from the integration event in which the
two origins of replication were in opposite orientations.
The technology for the mutagenesis of small fragments has been
available for some time and has been widely exploited. However,
the need to replace the mutagenized fragments in large genomic
clones has often been a limiting factor. The system described
in this paper for the relatively easy substitution of mutagenized
fragments of DNA has potential application in several areas, as
we have shown. Firstly it can be used to generate mutations,
ranging from bp substitution to large deletions, in the regulatory
regions of genes in cosmids to be used in studies of gene
expression in cells or in transgenic mice. Here, the bacterial C-
AT coding region was inserted into the first exon of the RBP
gene using homologous recombination, an example of the use
of this technique for inserting reporter genes into the context of
a full length eukaryotic gene. We also generated a five bp
substitution in the LF-Al binding site, and a four bp substitution
in the LF-B1 binding site of the AlAT promoter (17) by
homologous recombination; this enabled us to use this technique
to cause small alterations in cis-acting elements whilst leaving
the rest of the gene intact. We were able to use the resulting
cosmids in transgenic mice, to study the effect of the disruption
of the binding sites for trans-acting factors without having any
alteration in the rest of the gene and its flanking sequences.
Secondly the technique can be useful in the generation of small
mutations, which have biological significance, in the coding
region of genes. We replaced exon five of a PiM AlAT clone
with the corresponding exon from a PiZ allele. Other genes may
be mutagenized in this way, for example to interfere with signals
within genes concerned with splicing or termination. In all, we
believe that this technique will have applications in many varied
fields.
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DISCUSSION
We have used the homologous recombination method to generate
examples of several different types of construct which can be
made using this technique . Obviously, there are other fields of
research which could benefit from applications of this technique.
Because we have not exploited this technique fillly enough to
provide a basis for statistical analysis we are not yet in a position
to make firm conclusions as to which features of this protocol
most influence the frequency of the desired recombination events.
Nevertheless, the technique was successful in each case described,
and furthermore the frequency of desired events (between 10-2
and 10-4) is high enough to present no real problem given that
we are dealing with an easily assayable event in bacterial cells.
The amount of work involved is no greater than for many other
cloning techniques. Whilst we are not able to establish precisely
the ideal size requirements of the fragments to be used in the
technique, achieved successful homologous recombination with
areas of homology ranging from 218 bp to 2100 bp.
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